A1. Melzer J, Iten F, et al. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed. 2009;16(4):217-226.
A2. Kienle GS, Glockmann A, et al. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res. 2009 Jun 11;28:79.
A3. Ostermann T, Raak C, et al. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer. 2009 Dec 18;9:451.
A4. Kienle GS, Kiene H. Review article: Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther. 2010 Jun;9(2):142-57.
A5. Huber R, Lüdtke H, et al. Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters – a placebo controlled clinical trial in healthy subjects. BMC Complement Altern Med. 2011;11:116.
A6. Ostermann T, Büssing A. Retrolective studies on the survival of cancer patients treated with mistletoe extracts: a meta-analysis. Explore (NY). 2012;8(5):277-281.
A7. Kim KC, Yook JH, et al. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. BMC Complement Altern Med. 2012 Oct 3;12:172.
A8. Bar-Sela G, Wollner M, et al. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study. Eur J Cancer. 2013 Mar;49(5):1058-1064.
A9. Tröger W, Galun D, et al. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer. 2013 Dec;49(18):3788-3797.
A10. Tröger W, Galun D, et al. Quality of life in patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Dtsch Arztabl Int. 2014;111(29-30):493-502.
A11. Pelzer F, Tröger W, et al. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study. J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961.
A12. Freuding M, Keinki C, et al. Mistletoe in oncological treatment: a systematic review : Part 2: quality of life and toxicity of cancer treatment. J Cancer Res Clin Oncol. 2019 Apr;145(4):927-939.
A13. Freuding M, Keinki C, et al. Mistletoe in oncological treatment: a systematic review: Part 1: survival and safety. J Cancer Res Clin Oncol. 2019 Mar;145(3):695-707.
B1. Kienle GS, Grugel R, et al. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters. BMC Complement Altern Med. 2011 Aug 28;11:72. doi: 10.1186/1472-6882-11-72. Review. PubMed PMID: 21871125; PubMed Central PMCID: PMC3180269.
B2. Izzo AA. Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012;21(5):404-428.
B3. Teschke R, Wolff A, et al. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int. 2012 Nov;32(10):1543-1556.
B4. Posadzki P, Watson LK, et al. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond). 2013 Feb;13(1):7-12.
B5. Posadzki P, Watson L, et al. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2013 Mar;75(3):603-618.
B6. Huber R, Schlodder D, et al. Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer. BMC Complement Altern Med. 2017 Sep 18;17(1):465.